With the most comprehensive tools for cardiovascular evaluation, consumers will be able to review all cardiac and vascular structures including heart valves, chambers, walls etc. and be provided the most relevant data including myocardial perfusion and coronary flow reserve. Q’s technology will also enable the evaluation of all blood vessels for plaque burden and risk assessment. Currently, PET/MRI is being used in Europe for the stratification of stroke risk. The technology offers significantly more information than standard of care in the Americas including Carotid Duplex ultrasonography and MR Angiography of carotid arteries. At this time, no PET/MRI program in the US is offering this service.